Schedule 13D ownership disclosure

Odonate Therapeutics, Inc.

Security class unavailable · CUSIP: 676079106

Event date: 2018-11-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,340,738
Percent of class
8.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-18-007021
Form type
SC 13D/A
Filer
Odonate Holdings, LLC
CIK
CIK 1724078
Filed
Nov 09, 2018
Reporting period
Nov 01, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub